March 24 Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular risk by 22%, a new study finds.
March 20 Needle-free diabetes management could be on the horizon, study suggests Researchers in Japan developed an oral insulin pill that lowered blood sugar in diabetic mice, offering hope for a non-invasive alternative to injections.
March 18 Stopping Ozempic? New study reveals surprising weight regain results after GLP-1s New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.
March 17 Adult ADHD stimulant prescriptions are surging, and doctors are raising concerns Adult ADHD treatment has surged with stimulant prescriptions more than doubling since the COVID-19 pandemic began. A new study reveals a dramatic healthcare trend.
March 14 I was a doctor caring for Alzheimer’s patients. At 57, I became one. Here’s what’s next Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive function and quality of life.
March 13 Why Ozempic users are actually spending more on high-end chocolate A new report from Lindt & Sprüngli suggests households using GLP-1 weight-loss medications are driving stronger growth in premium chocolate sales, even as some research shows overall food spending declines.
March 9 Cannabis compounds could reverse disease affecting one-third of adults Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, according to a study released by the Hebrew University of Jerusalem.
March 8 Ancient herb known as ‘nature’s Valium’ touted for improving sleep and anxiety Experts weigh in on valerian root being called "nature's Valium" for anxiety, stress and sleep issues, warning that the comparison may be misleading for users.
March 7 GLP-1 drugs linked to higher fracture risk, osteoporosis and gout, new studies suggest A new study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with Type 2 diabetes compared to other diabetes medications.
March 5 Ozempic-style drugs could slash complication risks after heart attacks, research suggests Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking new research reveals.